Library
PubMed
research article
Professional

Declining antibiotic consumption and changing sexually transmitted infection dynamics in Japan: a national ecological time-series analysis, 2013-2024.

Source: PubMed, NCBI / U.S. National Library of Medicine

International journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesEriguchi Yoshihiro, Shimono NobuyukiPublished 5/16/2026Last synced 5/25/2026Status: syncedPMID: 42144158DOI: 10.1016/j.ijid.2026.108804

We examined whether declining antibiotic consumption in Japan coincided with changes in sexually transmitted infection (STI) indicators. We conducted a national ecological time-series analysis using annual data from 2013 to 2024. Antibiotic consumption was measured as defined daily doses per 1,000 inhabitants per day. Outcomes were syphilis from all-case surveillance and chlamydia and gonorrhea from sentinel surveillance. Log-linear regression models with appropriate offsets estimated incidence rate ratios (IRRs) per 10% increase in antibiotic consumption. Sensitivity analyses excluded the COVID-19 pandemic period. Overall antibiotic consumption declined substantially during the study period, whereas syphilis notifications increased markedly. Chlamydia increased gradually, and gonorrhea fluctuated. In primary analyses, a 10% increase in antibiotic consumption was associated with lower incidence of chlamydia (IRR 0.964, 95% CI 0.949-0.978) and gonorrhea (0.836, 0.758-0.922). The association with syphilis was imprecise and not statistically significant (0.836, 0.643-1.087). Sensitivity analyses excluding 2020-2022 yielded similar directional findings. Declining antibiotic consumption coincided with changes in some STI indicators in Japan, but associations were heterogeneous across infections. These ecological findings are hypothesis-generating and require further evaluation using more granular data.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.